Ultra high pressure homogenizer manufacturer

Ultra high pressure homogenizer manufacturers can make suspended materials flow at high speed through a special internal structure chamber (high-pressure homogenization chamber) under ultra-high pressure (Z can reach 60000psi), causing a series of changes in physical, chemical, and structural properties of the material, ultimately achieving homogenization.

　　Ultra high pressure homogenizer manufacturerApplication:

Preparation of fat granules, microemulsions, liposomes, suspensions, and microcapsules in the pharmaceutical industry;

Cell lysis, extraction and homogenization of intracellular and extracellular substances in biotechnology products;

Homogenization and emulsification of food and beverage industry products to improve product stability;

Homogenization and dispersion of products in industries such as cosmetics and fine chemicals;

Production and preparation of conductive paste and resistive paste.

　　Ultra high pressure homogenizer manufacturerIt is one of the most effective production equipment for preparing nanomaterials using nanotechnology processes, with a wide range of applications and a market demand of nearly 10 billion yuan.

Introduction:

It is mainly used in industries such as biology, medicine, food, and chemical engineering for cell lysis, beverage homogenization, and fine chemicals. It is used to prepare liposomes, fat emulsions, nanosuspensions, microemulsions, lipid microspheres, emulsions, dairy products, infusion solutions, dyes, solar panel coatings, and conductive coatings. The market size in this field exceeds 10 billion yuan. Among them, the production of pharmaceutical emulsions must adoptUltra high pressure homogenizerThe high-pressure homogenizer used in the domestic pharmaceutical industry is almost entirely dependent on imports, with a pressure of at least 20000 psi.

　　Ultra high pressure homogenizerDevelopment direction:

With the continuous development of manufacturing technology in China, many domestic homogenizers have been applied in various industries such as food and chemical. However, since the production of * batches of medicinal fat emulsions in China in 1986, almost all of the ultra-high pressure homogenizers used in the pharmaceutical industry have been imported. The main reason for this is that the core component of the domestically produced high-pressure homogenizer, the high-pressure homogenization chamber, cannot meet the technical requirements required by the industry.

Reduced blood supply to certain tissues may also cause ischemia or dysfunction in organs such as the brain, kidneys, liver, heart, lungs, etc. Therefore, in the pharmaceutical industry, it is not recommended to use * generation collision type homogenization equipment. The early products of collision type homogenization equipment commonly used in the industry and the vast majority of domestic models are no longer suitable for large-scale production of injectable emulsions.

In 2010, the US Food and Drug Administration (FDA) issued a notice recalling 11 batches of amlodipine butyrate injectable emulsion across the United States. The reason for the recall is that the product may contain inert metal particles. If these particles aggregate to form larger particles, theoretically it will lead to a decrease in capillary blood flow, which in turn can cause mechanical damage to certain tissues and trigger acute or chronic inflammatory reactions.

In the future, domestic high-pressure homogenizers need to continuously improve the manufacturing technology of the core component high-pressure homogenization chamber in order to be widely applied in high-precision fields such as medicine, semiconductor, microelectronics, etc.